Results 121 to 130 of about 249,531 (314)

Food and Drug Administration (FDA) History

, 2010
On this site, visitors can learn about the origins and history of the U.S. Food and Drug Administration. The navigation menu on the left will help move around the site to areas including Historical Case Studies of Product Regulation, History of FDA' ...

core  

A Systematic Study of GelMA‐Carbopol Bioinks for High‐Fidelity Extrusion 3D Bioprinting at Physiological Temperatures

Advanced Healthcare Materials, EarlyView.
Gonzalez Martinez and collaborators develop a strategy to formulate high performance GelMA‐based bioinks with low solids contents. The resulting bioinks enable 3D bioprinting at 37 °C of high‐fidelity structures with tunable mechanical properties that support high cell viability and function.
David A. González‐Martínez, Aidee V. Arizpe Tafoya, Eduardo González‐Martínez, Mabel Barreiro Carpio, Laura Daniela Serrano Andrade, Christopher T. N. Chow, Mohammadhossein Dabaghi, Jeremy A. Hirota, Jose M. Moran‐Mirabal   +8 more
wiley   +1 more source

United States Food and Drug Administration and the Pharmaceutical Industry [PDF]

BMJ, 1961
openaire   +2 more sources

Federal Food, Drug, and Cosmetic Act.

, 1999
Shipping list no.: 99-0269-P."As amended, February 1998."Cover title.Mode of access ...
United States., United States. Food and Drug Administration   +1 more
core  

Microgel‐Based 3D Bioprinting: A Convergent Strategy Integrating Material Design, Jamming Dynamics, and Biological Function

Advanced Healthcare Materials, EarlyView.
Microgel‐based 3D printed constructs represent a compelling and versatile innovation for engineering architecturally complex, dynamically remodelable, and biocompatible structures with high structural fidelity and bioactivity. By integrating material design, biofabrication, and biological function, these systems enable the development of adaptive ...
Elena Ghighină, Andreea Ioana Dinu, Jana Ghițman   +2 more
wiley   +1 more source

Genetic relatedness and virulence potential of Salmonella Schwarzengrund strains with or without an IncFIB-IncFIC(FII) fusion plasmid isolated from food and clinical sources

Frontiers in Microbiology
A total of 55 food and clinical S. Schwarzengrund isolates were assayed for plasmid content, among which an IncFIB-IncFIC(FII) fusion plasmid, conferring streptomycin resistance, was detected in 17 isolates.
Monique A. Felix, Monique A. Felix, Danielle Sopovski, Seth Commichaux, Noah Yoskowitz, Nesreen H. Aljahdali, Nesreen H. Aljahdali, Christopher J. Grim, Carter N. Abbott, Ashlyn Carlton, Ashlyn Carlton, Jing Han, Yasser M. Sanad, Yasser M. Sanad, Shaohua Zhao, Xiong Wang, Steven L. Foley, Bijay K. Khajanchi, Bijay K. Khajanchi   +18 more
doaj   +1 more source

Principles of food analysis for filth, decomposition, and foreign matter : analytical entomology for food-industry laboratories /

, 1981
"Second edition 1981."Previous ed. by U.S. Food and Drug Adminstration published under title: Microscopic analytical methods in food and drug control.Includes bibliographies and index.Mode of access ...
United States. Food and Drug Administration, Gorham, John Richard, 1931-, Amrine, James W., United States. Food and Drug Administration Microscopic analytical methods in food and drug control.   +3 more
core  

Neutrophil‐Mimetic MRI Enables Ultra‐Early Detection of Vascular Inflammation After Stroke

Advanced Healthcare Materials, EarlyView.
In this study, we developed neutrophil‐mimetic MRI probes that detect ultra‐early neuroinflammation following ischemic stroke by targeting E‐selectin. Within seconds of their injection, these microparticles mimic initial leukocyte adhesion to the activated cerebral endothelium.
Marion Isabelle Morvan, Damien Levard, Eloïse Lemarchand, Amal Boublay, Charly Helaine, Jolan Malherbe, Mikaël Naveau, Didier Goux, Igor Khalin, Ankita Talukdar, Cheun Pelleter, Charlène Jacqmarcq, Erwan Baudron, Isabelle Bardou, Sara Martinez de Lizarrondo, Maxime Gauberti, Denis Vivien, Antoine Philippe Fournier   +17 more
wiley   +1 more source

Development of a comprehensive open access “molecules with androgenic activity resource (MAAR)” to facilitate risk assessment of chemicals

Experimental Biology and Medicine
The increasing prevalence of endocrine-disrupting chemicals (EDCs) and their potential adverse effects on human health underscore the necessity for robust tools to assess and manage associated risks.
Fan Dong, Barry Hardy, Jie Liu, Tomaz Mohoric, Wenjing Guo, Thomas Exner, Weida Tong, Joh Dohler, Daniel Bachler, Huixiao Hong   +9 more
doaj   +1 more source

How the food label can help you plan a healthy diet.

, 1998
"April 1998"--P.
United States. Food and Drug Administration
core